Clinical Trial Evaluating the Safety and Efficacy of Nucleus Pulposus Allograft in Participants With Degenerative Disc Disease
for Degenerative Disc Disease
19 locations incl. Napa
Sponsor: VIVEX Biologics, Inc.
Sex: All·Age: 22 - 85
Code: NCT06778447·Recruiting